Crossmark

De-medicalization of birth by reducing the use of oxytocin for augmentation among first-time mothers – a prospective intervention study

Crossref DOI link: https://doi.org/10.1186/s12884-018-1706-4

Published Online: 2018-03-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gaudernack, L. C.

Frøslie, K. F.

Michelsen, T. M.

Voldner, N.

Lukasse, M.
License Information

Text and Data Mining valid from 2018-03-27
More Information

Article History

Received: 24 July 2017

Accepted: 15 March 2018

First Online: 27 March 2018

Ethics approval and consent to participate

: The Regional Committee for Health and Research Ethics (REC) considered the project to be a quality improvement project and stated that ethical approval was not necessary (REC number/Do. id: 206053/23. Aug. 2011). The Personal Data Officer (PVO) at the study stated that informed consent was not necessary.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.